SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020-2022

被引：3
|
作者：
Teran, Richard A. [1 ,2 ,3 ]
Gagner, Alexandra [2 ]
Gretsch, Stephanie [2 ]
Lauritsen, Jeff [2 ]
Galanto, Daniel [2 ]
Walblay, Kelly [2 ]
Ruestow, Peter [2 ]
Korban, Colin [2 ]
Pacilli, Massimo [2 ]
Kern, David [2 ]
Black, Stephanie R. [2 ]
Tabidze, Irina [2 ]
机构：
[1] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop H21-10, Atlanta, GA 30329 USA
[2] Chicago Dept Publ Hlth, Chicago, IL USA
[3] CDCP, 1600 Clifton Rd NE Mailstop H24-4, Atlanta, GA 30329 USA
来源：
EMERGING INFECTIOUS DISEASES | 2023年 / 29卷 / 11期
关键词：
CORONAVIRUS DISEASE 2019; UNITED-STATES; COVID-19; VACCINATION; INFECTION; ADULTS; HOSPITALIZATION; INDIVIDUALS; ILLNESS; RATES;
D O I：
10.3201/eid2911.230577
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Understanding if persons with HIV (PWH) have a higher risk for SARS-CoV-2 reinfection may help tailor future COVID-19 public health guidance. To determine whether HIV infection was associated with increased risk for SARS-CoV-2 reinfection, we followed adult longitudinally from their first reported infection through May 31, 2022. We matched SARS-CoV-2 laboratory data and COVID-19 vaccine administration data to Chicago's Enhanced HIV/AIDS Reporting System. Among 453,587 Chicago residents with SARS-CoV-2, a total of 5% experienced a SARS-CoV-2 reinfection, including 192/2,886 (7%) PWH and 23,642/450,701 (5%) persons without HIV. We observed higher SARS-CoV-2 reinfection incidence rates among PWH (66 [95% CI 57-77] cases/1,000 person-years) than PWOH (50 [95% CI adjusted rate of SARS-CoV-2 reinfection (1.46, 95% CI 1.27-1.68) than those without HIV. PWH should follow the recommended COVID-19 vaccine schedule, including booster doses.
引用
收藏
页码：2257 / 2265
页数：9
相关论文
共 50 条
  • [21] Transmission of SARS-CoV-2 among underserved pastoralist communities in Kajiado County, Kenya: 2020-2022
    Macharia, Zipporah
    Ogoti, Brian
    Otieno, Magdaline
    Gitonga, Pauline
    Bosco-Lauth, Angela
    Maritim, Marybeth
    Lemarkoko, Esther
    Keya, Aggrey
    Sankok, Joseph
    Gitao, George
    Onono, Joshua
    Oyugi, Julius
    Bowen, Richard A.
    PLOS ONE, 2024, 19 (08):
  • [22] Tracking Changes in SARS-CoV-2 Transmission with a Novel Outpatient Sentinel Surveillance System in Chicago, Illinois, USA
    Richardson, R.
    Arevalo, P.
    Jorgensen, E.
    Pacilli, M.
    Lightner, S.
    Cobey, S.
    Gerardin, J.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 116 : S96 - S96
  • [23] Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: A population-level observational study
    Medic, Snezana
    Anastassopoulou, Cleo
    Lozanov-Crvenkovic, Zagorka
    Vukovic, Vladimir
    Dragnic, Natasa
    Petrovic, Vladimir
    Ristic, Mioljub
    Pustahija, Tatjana
    Gojkovic, Zoran
    Tsakris, Athanasios
    Ioannidis, John P. A.
    LANCET REGIONAL HEALTH-EUROPE, 2022, 20
  • [24] Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020-2022
    Harrison, Rebecca E.
    Hamada, Ahmed
    Haswell, Nujcharee
    Groves, Aigul
    Vihta, Karina-Doris
    Cella, Kerry
    Garner, Sarah
    Walker, Ann Sarah
    Seale, Anna C.
    EMERGING INFECTIOUS DISEASES, 2023, 29 (10) : 2024 - 2031
  • [25] Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: A population-level observational study
    Medic, Snezana
    Anastassopoulou, Cleo
    Lozanov-Crvenkovic, Zagorka
    Vukovic, Vladimir
    Dragnic, Natasa
    Petrovic, Vladimir
    Ristic, Mioljub
    Pustahija, Tatjana
    Gojkovic, Zoran
    Tsakris, Athanasios
    Ioannidis, John P. A.
    LANCET REGIONAL HEALTH-EUROPE, 2022, 20
  • [26] Reinfection and reactivation of SARS-CoV-2
    Dowran, Razieh
    Damavandi, Amirmasoud Rayati
    Azad, Talat Mokhtari
    FUTURE VIROLOGY, 2022, : 835 - 844
  • [27] Risk of SARS-CoV-2 reinfection after natural infection
    Boyton, Rosemary J.
    Altmann, Daniel M.
    LANCET, 2021, 397 (10280): : 1161 - 1163
  • [28] Quantifying the risk of SARS-CoV-2 reinfection over time
    Murchu, Eamon O.
    Byrne, Paula
    Carty, Paul G.
    De Gascun, Cillian
    Keogan, Mary
    O'Neill, Michelle
    Harrington, Patricia
    Ryan, Mairin
    REVIEWS IN MEDICAL VIROLOGY, 2022, 32 (01)
  • [29] Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions-United States, 2020-2022
    Bratcher, Anna
    Jones, Jefferson M.
    Meyer, William A., III
    Waheed, Rehan
    Yazgi, Huda
    Harris, Aaron
    Gundlapalli, Adi V.
    Clarke, Kristie E. N.
    PLOS ONE, 2025, 20 (01):
  • [30] Geographic and demographic heterogeneity of SARS-CoV-2 diagnostic testing in Illinois, USA, March to December 2020
    Holden T.M.
    Richardson R.A.K.
    Arevalo P.
    Duffus W.A.
    Runge M.
    Whitney E.
    Wise L.
    Ezike N.O.
    Patrick S.
    Cobey S.
    Gerardin J.
    BMC Public Health, 21 (1)
12345